hepatocellular carcinoma
Conditions
Interventions
Control Group (resection group):NA
Experimental Group (operation combined with intraperitoneal hyperthermic perfusion chemotherapy):NA
Sponsors
Zhujiang Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) according to the clinical diagnostic criteria of primary liver cancer (2022 edition) or confirmed by pathology/cytology, 2) preoperative diagnosis of rupture and hemorrhage of liver cancer was made by clinical manifestation, examination and imaging; 3) age 18-80 years old; 4) no surgery or systemic therapy (except interventional hemostasis) for the tumor before the initial operation; 5) Child-Pugh Class A or class B after liver protection and albumin correction, with no severe heart, lung or renal dysfunction and no absolute contraindication to surgery; 6) ECOG-PS score 0-1, with no other tumor disease; 7) no liver failure disease, 8) preoperative informed consent, 9) no postoperative major complications, such as massive hemorrhage, purulent infection, multiple organ failure, etc.
Exclusion criteria
Exclusion criteria: 1) having other active malignant tumor at the same time; 2) Child-pugh C grade with severe organic lesions of important organs and severe liver cirrhosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| abdominal recurrence-free survival(RFS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Over Survival;survival rate; | — |
Countries
China
Contacts
Public ContactMingxin Pan
Zhujiang Hospital of Southern Medical University
Outcome results
None listed